View Indications and Important Safety Information

Help close the gap.

Prolaryn Helps close the gap

A hypothetical patient profile:
Jeff S.

Age: 53

Diagnosed with oropharyngeal cancer with grossly uninvolved larynx: March 2010

Received 65 Gy of whole-field intensity-modulated radiotherapy (IMRT)

Patient presents with hoarseness

Referred to ENT for examination

Laryngoscopy confirms:

  • Bilateral vocal fold atrophy
  • Persistent glottal gap

Jeff S. is a candidate for short-term vocal fold medialization with PROLARYN GEL to evaluate augmentation before making a decision to undergo long-term augmentation with PROLARYN PLUS

See other patient profiles:

Parkinson’s Disease
Surgical Trauma

Not an actual patient.